| Original language | English (US) |
|---|---|
| Pages (from-to) | 273-274 |
| Number of pages | 2 |
| Journal | Annals of emergency medicine |
| Volume | 77 |
| Issue number | 2 |
| DOIs | |
| State | Published - Feb 2021 |
ASJC Scopus subject areas
- Emergency Medicine
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Annals of emergency medicine, Vol. 77, No. 2, 02.2021, p. 273-274.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - In Reply:
AU - Martinez, Diego A.
AU - Levin, Scott R.
AU - Hinson, Jeremiah S.
N1 - Funding Information: Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). Under a license agreement between StoCastic, LLC and Johns Hopkins University, the university owns equity in StoCastic and is entitled to royalty distributions related to the technology described in this article. Dr. Levin serves as StoCastic's chief technology officer and is the cofounder of the company. Dr. Hinson serves as StoCastic's chief medical officer and owns equity in the company. These arrangements have been reviewed and approved by Johns Hopkins University in accordance with its conflict of interest policies. This work was supported by a Pilot Project Award from the Emergency Medicine Foundation (Dr. Hinson). Dr. Martinez is supported by the Centers for Disease Control and Prevention (CDC) and the Agency for Healthcare Research and Quality (AHRQ). Dr. Hinson is supported by the National Institutes of Health (NIH), CDC, and AHRQ. Dr. Levin is supported by the NIH, CDC, AHRQ, and the National Science Foundation. Funding Information: Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org ). Under a license agreement between StoCastic, LLC and Johns Hopkins University, the university owns equity in StoCastic and is entitled to royalty distributions related to the technology described in this article. Dr. Levin serves as StoCastic’s chief technology officer and is the cofounder of the company. Dr. Hinson serves as StoCastic’s chief medical officer and owns equity in the company. These arrangements have been reviewed and approved by Johns Hopkins University in accordance with its conflict of interest policies. This work was supported by a Pilot Project Award from the Emergency Medicine Foundation (Dr. Hinson). Dr. Martinez is supported by the Centers for Disease Control and Prevention (CDC) and the Agency for Healthcare Research and Quality (AHRQ) . Dr. Hinson is supported by the National Institutes of Health (NIH) , CDC, and AHRQ. Dr. Levin is supported by the NIH, CDC, AHRQ, and the National Science Foundation.
PY - 2021/2
Y1 - 2021/2
UR - http://www.scopus.com/inward/record.url?scp=85099667470&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85099667470&partnerID=8YFLogxK
U2 - 10.1016/j.annemergmed.2020.09.005
DO - 10.1016/j.annemergmed.2020.09.005
M3 - Letter
C2 - 33487322
AN - SCOPUS:85099667470
SN - 0196-0644
VL - 77
SP - 273
EP - 274
JO - Annals of emergency medicine
JF - Annals of emergency medicine
IS - 2
ER -